Fleet Prep Kit 3 (bisacodyl / sodium biphosphate / sodium phosphate) and Alcohol / Food Interactions
There is 1 alcohol/food/lifestyle interaction with Fleet Prep Kit 3 (bisacodyl / sodium biphosphate / sodium phosphate):
sodium biphosphate ↔ food
Moderate Food Interaction
Consumer information for this interaction is not currently available.
ADJUST DOSING INTERVAL: Bowel cleansing products can increase the gastrointestinal transit rate. Oral medications administered within one hour of the start of administration of the bowel cleansing solution may be flushed from the gastrointestinal tract and not properly absorbed.
MANAGEMENT: Patients should be advised that absorption of oral medications may be impaired during bowel cleansing treatment. Oral medications (e.g., anticonvulsants, oral contraceptives, antidiabetic agents, antibiotics) should not be administered during and within one hour of starting bowel cleansing treatment whenever possible. However, if concomitant use cannot be avoided, monitoring for reduced therapeutic effects may be advisable.
- "Product Information. Golytely (polyethylene glycol electrolyte solution)." Braintree, Braintree, MA.
- "Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate)." Ferring Pharmaceuticals Inc, Tarrytown, NY.
Fleet Prep Kit 3 (bisacodyl / sodium biphosphate / sodium phosphate) drug interactions
There are 723 drug interactions with Fleet Prep Kit 3 (bisacodyl / sodium biphosphate / sodium phosphate)
Fleet Prep Kit 3 (bisacodyl / sodium biphosphate / sodium phosphate) disease interactions
There are 6 disease interactions with Fleet Prep Kit 3 (bisacodyl / sodium biphosphate / sodium phosphate) which include:
- sodium/water balance
- inflammatory bowel disease
- intestinal obstruction disorders
- electrolyte imbalance
- acute surgical abdomen
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.